Delivery Order SPE2DB24D2205-SPE2DB25FEGDR
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 29, 2025, for the supply of Nayzilam 5 mg nasal sprays, with a ceiling value of $1,043.25. This is a firm fixed price, competitively awarded contract with no set-aside designation. The delivery order is performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of July 30, 2025. This award represents a child contract under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Nayzilam 5 mg nasal sprays, valued at $1,043.25. The contract was competitively awarded without set-aside designation on August 26, 2025, with an ultimate completion date of August 27, 2025. AmerisourceBergen will perform the work from its corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 11, 2025, for the supply of Nayzilam 5 mg nasal sprays with a contract ceiling value of $1,987.32. This firm fixed-price delivery order, which is non-competitive and set-aside-free, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The pharmaceutical...
- The Defense Logistics Agency awarded a delivery order valued at $2,086.50 to AmerisourceBergen Drug Corp for the supply of Nayzilam 5 mg nasal sprays. This competitive award, issued on June 4, 2025, with an ultimate completion date of June 5, 2025, represents a firm fixed-price delivery order with no set-aside designation. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order valued at $2,965.52 to AmerisourceBergen Drug Corp for Nayzilam 5 mg nasal sprays. This firm fixed-price, competitively awarded contract was issued on August 28, 2025, with an ultimate completion date of August 29, 2025. The pharmaceutical products will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order valued at $4,218.76 to AmerisourceBergen Drug Corp for the supply of Nayzilam 5 mg nasal sprays. This competitively awarded, firm fixed-price contract was executed on August 13, 2025, with an ultimate completion date of August 14, 2025. The contract is performed from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a $1,309.22 firm fixed-price delivery order to AmerisourceBergen Drug Corp on September 2, 2025, for the supply of Nayzilam 5 mg nasal sprays. The contract, which is non-set-aside and competitively awarded, is set for completion by September 3, 2025, with performance occurring at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order valued at $1,827.04 to AmerisourceBergen Drug Corp for the supply of Nayzilam 5 mg nasal sprays under a firm fixed price contract. The award was made on July 24, 2025, with an ultimate completion date of July 25, 2025, and represents a non-competitive, non-set-aside procurement. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order is issued...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, for $1,100 in Nayzilam 5 mg nasal sprays. This non-set-aside, competitively awarded contract employs firm fixed pricing and maintains a completion deadline of September 15, 2025. The delivery order represents a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical...
- The Defense Logistics Agency awarded a $2,216.18 delivery order to AmerisourceBergen Drug Corp for Nayzilam 5 mg nasal sprays under a firm fixed price contract with an ultimate completion date of September 18, 2025. This is a non-set-aside, competitively awarded delivery order issued as a child contract against AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which carries a ceiling value of $999,999,999.00 and extends through December 2026. The...
- SPE2DB24D2205Indefinite Delivery Contract
- SPE2DB24D2205-SPE2DB25FEGDRDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,391.00 to AmerisourceBergen Drug Corp for the supply of Nayzilam 5 mg nasal spray. This firm fixed price contract, awarded on August 12, 2025, represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The delivery order carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with completion targeted for August 13, 2025. AmerisourceBergen Drug Corp is a major pharmaceutical distributor providing critical medical supply support to federal healthcare systems, including military and veteran programs. The company maintains extensive competitive contract awards with the Defense Logistics Agency covering a broad pharmaceutical portfolio spanning specialty medications, generics, vaccines, and medical devices. This delivery order for Nayzilam nasal spray—an emergency seizure medication—supports DLA's ongoing medical supply requirements for military healthcare operations and represents a routine transactional commitment within the vendor's established framework for federal pharmaceutical procurement.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.4k | 8/12/25 |